Home » Trudeau says J&J vaccine faces manufacturing challenges

Trudeau says J&J vaccine faces manufacturing challenges

by newsking24

Prime Minister Justin Trudeau stated immediately Canada has been warned of producing issues plaguing the Johnson & Johnson vaccine.

The viral vector vaccine developed by J&J’s subsidiary, Janssen Pharmaceuticals, was approved by Health Canada as secure and efficient final week.

Canada pre-ordered 10 million doses of the vaccine, which is the primary and just one in Canada’s vaccine plan that requires just one dose.

But Trudeau stated Canada nonetheless would not have a goal date for the primary deliveries.

“We have heard in many conversations with Johnson & Johnson that there are challenges around production of the Janssen vaccine, but we will continue to engage with them and we look forward to receiving doses as soon as possible,” he stated immediately at a information convention in Ottawa.

“And as soon as we get confirmation of doses being sent to Canada, we will let everyone know.”

Canada’s vaccine rollout stepped up this month after deliveries slowed to a trickle in February. Nearly a million doses of Pfizer-BioNTech and Oxford-AstraZeneca vaccines had been delivered final week, and 910,000 doses of Pfizer and Moderna are arriving this week.

It took Canada 67 days to vaccinate the primary a million individuals. It will take lower than one-third of that point to vaccinate the second million.

As of midday on Tuesday, greater than 1.9 million Canadians have now acquired at the very least one dose.

Canada not prepared but to situation steerage on enjoyable measures 

Chief Public Health Officer Dr. Theresa Tam stated Canada is not fairly able to comply with the U.S. Centers for Disease Control and situation steerage on how vaccinated people can loosen up their public well being measures.

The CDC stated Monday that these Americans who acquired their second dose at the very least two weeks in the past can now go to indoors, with out masks, with different totally vaccinated individuals, or with those that should not vaccinated however are at low threat of great sickness.

Tam stated there are nonetheless too many unknowns, together with the impact of COVID-19 variants and the way vaccines will have an effect on the unfold of the novel coronavirus.

“So I think we need to take a thoughtful approach, but it is important that we have to evolve our public health approach as more Canadians are getting vaccinated,” she stated.

The United States is way forward of Canada, having now vaccinated multiple in 4 individuals. Canada has vaccinated about one in 20.

Tam stated there are “initial positive signs” that the Pfizer and Moderna vaccines are stopping transmission, in addition to decreasing the severity of sickness, however it’s nonetheless early.

The emergence of variants that are not all responding as properly to vaccines can be a priority, she stated. Tam stated Ontario now believes nearly one-third of its new instances are a kind of variants, with the B.1.1.7 variant first recognized within the United Kingdom the commonest.

That variant additionally seems to be probably the most receptive to the present vaccines.

The variety of new instances in Canada has plateaued at about 2,900 instances per day within the final couple of weeks, however the variety of individuals dying seems to be diminishing.

WATCH | Trudeau addresses challenges Johnson and Johnson face in vaccine manufacturing

Prime Minister Justin Trudeau addresses manufacturing challenges Johnson & Johnson is going through with its COVID-19 vaccine. 0:53

On Feb. 23, Tam reported a one-week common of two,900 new instances and 54 deaths per day. On March 2, the weekly common was 2,933 instances and 42 deaths. On Tuesday, it was 2,900 new instances per day and 37 deaths.

Newfoundland and Labrador additionally appears to be recovering from a serious outbreak that swept by St. John’s final month. Public well being officers reported one new case Tuesday and stated energetic infections are all the way down to 80, from 203 per week in the past.

Johnson & Johnson hasn’t even but confirmed for Canada the place its vaccine doses shall be made. The firm is producing the vaccine within the U.S. and Europe, and Health Canada has approved services in each locations to make it.

But neither the corporate nor Canadian officers will say but the place Canada’s doses shall be made. The United States is not permitting exports of doses made there till the U.S. is totally served, however which will occur by late May.

Still, J&J’s manufacturing issues are affecting Europe and the U.S. as properly. Several European nations, the place the vaccine is not but approved, stated they do not count on as many doses of it subsequent month as initially deliberate.

U.S. President Joe Biden stated final week that when he took workplace, he was knowledgeable that Johnson & Johnson was behind on manufacturing and efforts started to search out further manufacturing house. Sanofi was first contracted to assist produce the vaccine in Europe and final week Biden introduced Merck would assist produce it within the United States.


Source hyperlink

Related Articles

Leave a Reply

Select Language »
%d bloggers like this: